1 – 10 of 602
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Blood Biomarkers to Detect Alzheimer Disease-Reply
(
- Contribution to journal › Letter
-
Mark
Associations between the EAT-Lancet planetary health diet and incident dementia
(
- Contribution to journal › Article
-
Mark
GBA1 T369M and Parkinson's disease - Further evidence of a lack of association in the Swedish population
(
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
(
- Contribution to journal › Article
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
(
- Contribution to journal › Article
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Toward a biological definition of neuronal and glial synucleinopathies
(
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
(
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
2025) In Brain : a journal of neurology(
- Contribution to journal › Article